Induced sputum (IS) examination in immunocompromised children for *Pneumocystis jirovecii* and for suspected *Mycobacterium tuberculosis* is the standard of care \[[@CIT0001]\]. Given its utility in this subset of children, there has been increased interest in its use for pneumonia diagnosis in children more generally \[[@CIT0005]\]. While several small studies have found that the IS procedure was well tolerated in children, and produced quality specimens for pneumonia pathogen identification \[[@CIT0002], [@CIT0006]\], there have been no large-scale studies evaluating the safety of this procedure in children with severe and very severe pneumonia. We describe the safety profile of the IS procedure performed at 9 sites in 7 countries, among a heterogeneous population of children 1--59 months of age hospitalized with severe and very severe pneumonia.

METHODS {#s1}
=======

IS specimens were collected from cases enrolled in the Pneumonia Etiology Research for Child Health (PERCH) study, a 9-site, 7-country case-control study of World Health Organization (WHO)--defined severe or very severe pneumonia in hospitalized children and community controls aged 1--59 months, to estimate the causes of pneumonia in children. The study design and methods have been described elsewhere, and training materials as well as study documents are publically available describing the standardized methods that were used across heterogeneous settings and populations \[[@CIT0007]\]. The PERCH study protocol was approved by the institutional review board or ethical review committee at each of the study site institutions and at the Johns Hopkins Bloomberg School of Public Health. Parents or guardians of all participants provided written informed consent.

Protocol Development {#s2}
--------------------

During the PERCH study design phase, experts in pediatric respiratory disease were asked to synthesize the evidence on the safety and utility of IS collection in children \[[@CIT0005]\]. After considering the risks and benefits, 16 pediatric pneumonia experts endorsed the collection of IS in PERCH, particularly for detection of tuberculosis and pneumocystis pneumonia. These same experts also recommended that IS be obtained from all PERCH cases using nebulization with hypertonic saline, excepting those children with a clear contraindication, such as hypoxia \[[@CIT0005]\].

Of the 9 sites (in 7 countries) selected to be part of PERCH in 2010, 2 (Kenya and South Africa) were already collecting IS specimens as part of routine clinical care from children hospitalized with pneumonia, and 1 site solely for study purposes (The Gambia). A standardized operating procedure (SOP) based on the techniques used by these sites was developed and agreed upon by all investigators \[[@CIT0011]\]. To facilitate cross-site collaboration and standardization of methods, teams without experience in IS collection were trained by experienced study investigators from sites using the procedure routinely. Because 6 of the 9 sites initiated sputum collection as a new study procedure, we implemented standardized clinical monitoring for all sites to assess the procedure safety and ensure the safety of study participants \[[@CIT0012]\].

IS Procedure {#s3}
------------

The IS procedure is described in detail in accompanying papers \[[@CIT0013], [@CIT0014]\]. In brief, at the time of IS collection, a nebulized β-agonist was administered to enrolled PERCH cases, followed by inhaled nebulized 5% hypertonic saline (to induce expectoration). Sputum was collected using a sterile catheter passed through the nose and suction was applied to aspirate the contents of the posterior nasopharynx. Without suction, the catheter was then removed from the nose and flushed with sterile normal saline into a closed mucous trap. The specimen was collected within 24 hours of admission whenever possible, among children without contraindications (see below).

In South Africa, \>1 IS specimen was routinely collected from each child to enhance the detection of *M. tuberculosis*. At other sites, an additional IS specimen for tuberculosis diagnosis was collected at the discretion of the clinical provider. Multiple specimens from the same child were not pooled, as the second specimen was collected \>24 hours after the first for children in whom tuberculosis was suspected.

Contraindications to collection of IS included oxygen saturation \<92% on supplemental oxygen, inability to protect airway, severe bronchospasm, seizure within the preceding 24 hours, or deemed inadvisable by the treating physician. Children who underwent IS collection were closely monitored before, during, and after the procedure. Clinical measures including oxygen saturation and oxygen requirement, respiratory rate, and consciousness level (using the alert, voice, pain, unresponsive \[AVPU\] scale) were recorded immediately before and after the IS procedure, as well as at 30 minutes, 2 hours, and 4 hours following the procedure. Criteria for stopping the procedure were oxygen saturation ≤88% for \>60 seconds or oxygen saturation of 89%--91% for \>60 seconds despite an increase in supplemental oxygen. If after a period of stabilization or rest the child's respiratory status improved to their preprocedure baseline status, IS collection was resumed when oxygen saturation was ≥92% for 5 minutes or more. If the oxygen requirement remained greater than the requirement prior to the procedure, the IS procedure was only restarted after careful evaluation of the child's clinical status and stability, noting possible disease progression and the magnitude of change in oxygen requirement.

Severe Adverse Event Reporting {#s4}
------------------------------

In collaboration with the ethical review boards that approved the study, 4 criteria were established for categorizing a change in clinical status as a serious adverse event (SAE) in PERCH cases undergoing IS specimen collection. These 4 conditions were reported as SAEs if they occurred any time between the initiating the procedure and 4 hours postprocedure: (1) death (for any reason); (2) drop in oxygen saturation by ≥5% for at least 15 minutes; (3) new onset of unconsciousness or prostration; and (4) new requirement for bronchodilator or increased frequency of bronchodilator treatment. Each site assigned an independent clinician to be the site safety monitor for the study, and when an SAE occurred, the study staff completed a report describing the event. The site safety monitor was responsible for reviewing each SAE report and determining whether the event could be attributed to a specific procedure. Relatedness was assigned as definitely, probably, possibly, and probably not. Reports were then submitted for review to the PERCH study-wide safety monitor, a physician who had no other investigator role in the PERCH study, and were forwarded to the Johns Hopkins University Institutional Review Board (IRB) and the site ethical review board(s).

The above monitoring and SAE reporting criteria were developed to safeguard children with severe respiratory illness from developing complications due to a study procedure. At least 1 study investigator from each site (usually the primary study clinician) participated in a PERCH Clinical and Epidemiology Working Group that reviewed the contraindications for IS collection, the criteria for defining SAEs, and the SAEs as they occurred.

Statistical Analysis {#s5}
--------------------

We performed a descriptive analysis, calculating frequencies for categorical variables and medians and interquartile ranges for continuous variables, to compare the safety parameters at the various clinical monitoring time points. Given that the PERCH guidelines specified collection of 1 IS specimen and that children from whom a second IS specimen was collected may have differed from those with 1 IS, risks were calculated separately for the first IS and the second IS. Also, separately for the first and second IS, McNemar χ^2^ test was used to assess differences in oxygen requirement, saturation, and respiratory rate before and after the IS procedure.

RESULTS {#s6}
=======

Over the course of a 24-month enrollment period at each site, 3802 of 4232 (90%) enrolled PERCH patients underwent a procedure for induction of sputum. Of these, 851 patients had a second procedure, though 92% of these second procedures took place in one site, South Africa. In total there were 4653 procedures. A total of 3362 patients (88%) underwent an induction of sputum procedure within 24 hours of hospital admission. For the remaining 439 with the first specimen taken after 24 hours, 337 (77%) had an initial contraindication for the procedure: 102 (23%) had specimen collection deemed inadvisable by treating clinicians; 71 (16%) had a seizure in the 24 hours before being assessed for the procedure; 64 (15%) had severe bronchospasm; 63 (14%) had oxygen saturation \<92%; and 37 (8%) were unable to protect their airway. The remaining 102 (23%) participants had no specified contraindication.

###### 

Characteristics of Pneumonia Etiology Research for Child Health (PERCH) Study Cases With Induced Sputum Collection

  ------------------------------------------------------------------------------------------------------------------
  Characteristic                         Children With\   Children With\     All Children\       All IS Specimens\
                                         1 IS Specimen\   \>1 IS Specimen\   With IS Specimen\   (N = 4653)
                                         (n = 2951)       (n = 851)^a^       (n = 3802)          
  -------------------------------------- ---------------- ------------------ ------------------- -------------------
  Age                                                                                            

   1 mo to \<6 mo                        1139 (38.6)      410 (48.2)         1549 (40.7)         1959 (42.1)

   6--11 mo                              649 (22.0)       212 (24.9)         861 (22.6)          1073 (23.1)

   12--23 mo                             705 (23.9)       156 (18.3)         861 (22.6)          1017 (21.9)

   24--59 mo                             458 (15.5)       73 (8.6)           531 (14.0)          604 (13.0)

  Severity                                                                                       

   Severe                                2114 (71.6)      599 (70.4)         2713 (71.4)         3312 (71.2)

   Very severe                           837 (28.4)       252 (29.6)         1089 (28.6)         1341 (28.8)

  Sex                                                                                            

   Female                                1210 (41.0)      385 (45.2)         1595 (42.0)         1980 (42.6)

   Male                                  1741 (59.0)      466 (54.8)         2207 (58.0)         2673 (57.4)

  HIV status^b^                                                                                  

   Positive                              112 (3.8)        93 (10.9)          205 (5.4)           298 (6.4)

   Negative                              2527 (85.6)      751 (88.2)         3278 (86.2)         4029 (86.6)

   Unknown                               312 (10.6)       7 (0.8)            319 (8.4)           326 (7.0)

  HIV exposure^c^                                                                                

   Exposed                               267 (9.0)        353 (41.5)         620 (16.3)          973 (20.9)

   Unexposed                             2370 (80.3)      460 (54.1)         2830 (74.4)         3290 (70.7)

   Unknown                               314 (10.6)       38 (4.5)           352 (9.3)           390 (8.4)

  Receiving supplemental oxygen                                                                  

   At admission                          500 (16.9)       702 (82.5)^a^      1202 (31.6)         1904 (40.9)

   Ever^d^                               808 (27.4)       767 (90.1)         1576 (41.4)         2343 (50.4)

   Immediately prior to IS               524 (17.8)       577 (67.8)^e^      1101 (29.0)         1580 (34.0)

  Country/study site                                                                             

   Kilifi, Kenya                         550 (18.6)       44 (5.2)           594 (15.6)          638 (13.7)

   Basse, The Gambia                     588 (19.9)       8 (0.9)            596 (15.7)          604 (13.0)

   Bamako, Mali                          544 (18.4)       0 (0.0)            544 (14.3)          544 (11.7)

   Lusaka, Zambia                        517 (17.5)       1 (0.1)            518 (13.6)          519 (11.2)

   Soweto, South Africa                  56 (1.9)         785 (92.2)         841 (22.1)          1626 (34.9)

   Nakhon Phanom and Sa Kaeo, Thailand   190 (6.4)        1 (0.1)            191 (5.0)           192 (4.1)

   Dhaka and Matlab, Bangladesh          506 (17.2)       12 (1.4)           518 (13.6)          530 (11.4)
  ------------------------------------------------------------------------------------------------------------------

Data are presented as No. (%).

Abbreviations: HIV, human immunodeficiency virus; IS, induced sputum.

^a^Among children with \>1 IS, 92% were from the South African site where it was standard of care to place children with pneumonia on oxygen.

^b^HIV negative: negative polymerase chain reaction or enzyme-linked immunosorbent assay (ELISA) results, negative maternal test results at enrollment, or absence of evidence to indicate the child is positive in settings with limited HIV transmission (Bangladesh); HIV positive: detectable viral load or HIV seropositive if \>12 months old; HIV-unknown: insufficient evidence to define HIV status.

^c^HIV exposed: HIV positive, positive ELISA results (if \< 12 months) or positive maternal history (maternal history must be confirmed by maternal serology for seronegative infants \<7 months); HIV unexposed: (1) documented negative maternal HIV status, (2) \<7 months of age with a negative ELISA, or (3) ≥7 months with a negative ELISA result and reported, but undocumented, negative maternal history; unknown HIV exposure: insufficient evidence to define HIV exposure status.

^d^At admission or 24 hours after IS collection or 48 hours after IS collection.

^e^Children with \>1 IS included in numerator if they received oxygen immediately before either IS procedure.

Thirteen SAEs were reported following the IS procedure, representing a risk of 0.34% per child undergoing the procedure (0.34% for the first IS and 0.0% for the second IS; [Table 2](#T2){ref-type="table"}). The most common SAE (n = 9 \[69%\]) was a drop in oxygen saturation that required an increase in the amount of oxygen administered or the initiation of oxygen administration. The clinical condition of 8 of these children stabilized within the 4-hour monitoring period and 1 child stabilized after a longer period (\>12 hours). One child met the SAE criteria for increased need for bronchodilator nebulization. One child experienced a change in level of consciousness, which was attributed by the safety monitors to a preexisting condition and not to the procedure itself.

###### 

Serious Adverse Events Reported After Initiating First Induced Sputum Procedure^a^ in Pneumonia Etiology Research for Child Health (PERCH) Study Cases

  -------------------------------------------------------------------------------------------------------
  Serious Adverse Event                                              No.   Risk of Event per Procedure\
                                                                           (n = 3802), %
  ------------------------------------------------------------------ ----- ------------------------------
  Total                                                              13    0.34

  Drop in oxygen saturation                                          9     0.23

  New requirement or increased need for bronchodilator               1     0.03

  New onset of unconsciousness or prostration                        1     0.03

  Death within 4 h of initiating the IS procedure (for any reason)   2     0.05

  Category of relatedness to IS procedure                                  

   Definitely                                                        4     0.10

   Probably                                                          1     0.03

   Possibly                                                          5     0.13

   Probably not                                                      3     0.08
  -------------------------------------------------------------------------------------------------------

Abbreviation: IS, induced sputum.

^a^No serious adverse events occurred after the second IS. Table restricted to first induced sputum procedures to avoid double counting subset of children who underwent a second IS procedure in denominator.

The 13 SAEs included 2 deaths within 4 hours after the procedure. One of these deaths, in a child 5 months of age with very severe pneumonia who developed severe respiratory distress 2 hours after the IS procedure while breastfeeding and could not be resuscitated, was categorized as "possibly related" to IS collection. Another death was determined to be "probably not related" and occurred in a 16-month-old child with very severe pneumonia who was stable for \>2 hours after the IS procedure but suffered a cardiorespiratory arrest during feeding and could not be resuscitated ([Table 3](#T3){ref-type="table"}). All but 1 of the SAEs occurred at some point during the procedure or within 2 hours. Five SAEs occurred during the procedure, 1 occurred 30 minutes after the procedure, and 6 more occurred between 30 minutes and 2 hours post-IS. The single SAE that occurred \>2 hours after the procedure is described above as the 16-month-old child who died during feeding approximately 3.5 hours after IS collection, with the death being assessed as a likely aspiration event ([Table 3](#T3){ref-type="table"}).

###### 

Description of Serious Adverse Events Occurring Within 4 Hours of Initiating the Induced Sputum Procedure

  Pneumonia Severity   Age     Sex   Adverse Event                                                Relatedness              Details                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Outcome
  -------------------- ------- ----- ------------------------------------------------------------ ------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------
  Very severe          6 mo    F     Drop in oxygen saturation \<92% requiring increased oxygen   Definitely               Approximately 10 min into the procedure, the child's oxygen saturation dropped below 92% for \>10 min. The child's clinical status stabilized to stable within an hour, and the oxygen saturation stabilized at 95%--98% on room air.                                                                                                                                                                                                                                                                                                                                                                                                        Resolved
  Very severe          2 mo    M     New requirement for bronchodilator                           Definitely               During the procedure, child required increased bronchodilator nebulization to stabilize his oxygen saturation levels, which had been steady on supplemental oxygen prior to the procedure. Bronchodilators were administered for 15 min, and by 1 h postprocedure the child was stable, without continuing need for bronchodilators.                                                                                                                                                                                                                                                                                                         Resolved
  Very severe          23 mo   M     Drop in oxygen saturation \<92% requiring increased oxygen   Definitely               Child with cyanotic heart disease experienced a drop in measured oxygen saturation from 96% on room air to 74% while receiving nebulized hypertonic saline. Oxygen was administered, and the child was clinically stable at 4 h postprocedure. Study clinicians and the local safety monitor determined that the preprocedure oxygen saturation levels may have been noted incorrectly before initiating the IS procedure.                                                                                                                                                                                                                   Diagnosis of cyanotic heart disease
  Severe               3 mo    F     Drop in oxygen saturation \<92% requiring increased oxygen   Definitely               Child experienced an increased oxygen requirement between 30 min and 2 h postprocedure, and a ward pediatrician recommended a switch from nasal prong O~2~ at 2 L/min to a polymask at 10 L/min based on the advice of the attending physician. By 8 h postprocedure, the child had been weaned back to nasal prong oxygen and was clinically stable.                                                                                                                                                                                                                                                                                        Resolved
  Very severe          3 mo    M     Drop in oxygen saturation \<92% requiring increased oxygen   Possibly                 A child on supplemental oxygen who had stable clinical signs for 2 hours postprocedure was taken off the ward by a guardian. When study staff located the child for the 4-h postprocedure clinical monitoring, he was found to have an oxygen saturation of 80%. Supplemental oxygen was delivered; however, the child's guardian continued to remove the oxygen, and the child did not stabilize until 48 h after the procedure, as oxygen delivery was continuously disrupted.                                                                                                                                                             Resolved
  Severe               1 mo    F     Drop in oxygen saturation \<92% requiring increased oxygen   Possibly                 30 min after the IS procedure, the child's oxygen saturation fell to 90% for \>10 min. Supplemental oxygen was administered; the child's clinical status resolved by 4 h post-IS with an oxygen saturation of 94%--96% on room air.                                                                                                                                                                                                                                                                                                                                                                                                          Resolved
  Severe               8 mo    M     Drop in oxygen saturation \<92% requiring increased oxygen   Possibly                 Child's oxygen saturation fell to 95% from 100% and work of breathing increased at 30 min post-IS. An attending physician felt the child required intubation at 1--2 h post-IS for increased work of breathing. At 4 h post-IS, the child had a respiratory rate of 62/min and an oxygen saturation of 98%. The child was extubated 7 d later.                                                                                                                                                                                                                                                                                               Resolved
  Severe               3 mo    M     Drop in oxygen saturation \<92% requiring increased oxygen   Possibly                 Oxygen saturation dropped to 67% from 95% on 2 L/min nasal prong oxygen in a child with extensive multilobar pneumonia during the NP aspiration part of the IS procedure. The procedure was stopped and the oxygen saturation normalized with continued nasal prong oxygen at 2 L/min. At 4 h post-IS, the child had a respiratory rate of 86/min and 100% oxygen saturation on 12 L/min polymask oxygen. Over the ensuing several hours the child's respiratory status deteriorated, with increasing work of breathing and oxygen requirement leading to intubation 12 h following the procedure. The child self-extubated 6 d later.       Resolved
  Severe               5 mo    F     Death                                                        Possibly                 IS collected without event in a child with 98% oxygen saturation on room air. Postprocedure respiratory rate was 78 breaths/min. During breastfeeding 1 h post-IS, the child developed severe respiratory distress and died despite resuscitation efforts 2 h after the procedure. The cause of death was assessed as a likely aspiration event.                                                                                                                                                                                                                                                                                             Death
  Severe               30 mo   M     Drop in oxygen saturation \<92% requiring increased oxygen   Probably                 During the nebulization with hypertonic saline, the child's oxygen saturation fell to 88%--92%. Low flow oxygen was started and administered for 50 min postprocedure, without attempting to wean the child off oxygen. The child's oxygen saturation was \>92% at 2 and 4 h postprocedure on room air.                                                                                                                                                                                                                                                                                                                                      Resolved
  Very severe          3 mo    M     Drop in oxygen saturation \<92% requiring increased oxygen   Probably not             Child experienced a seizure 1 h after the IS procedure. The child had a seizure in the 24 h prior to IS collection, which is a contraindication for the procedure. However, this was not communicated to the PERCH physician who performed the IS procedure. The procedure was stopped during the NP suctioning because of transient desaturation to 80% with O~2~ saturation returning to 95% within 60 sec of catheter withdrawal. An hour after the IS procedure was started, the child experienced another seizure. At 4 h after the IS procedure, the child was alert with an oxygen saturation of 99% on 2 L/min nasal prong oxygen.   Resolved
  Very severe          16 mo   F     Death                                                        Probably not             Child with very severe pneumonia and early signs of malnutrition was stable more than 2 h after specimen collection. Child developed dyspnea while being fed milk by her father and could not be resuscitated. The cause of death was assessed as a likely aspiration event.                                                                                                                                                                                                                                                                                                                                                                 Death
  Very severe          11 mo   F     New onset of unconsciousness or prostration                  Probably not/ unlikely   Child was stable for 1 h after the IS procedure. 90 min after the procedure, the child developed respiratory distress immediately following feeding. Two contraindications (history of seizure and inability to protect airways) should have been noted for this case. By 4 h post-IS, the child had oxygen saturation of 85% on room air, which improved to 96% on supplemental oxygen.                                                                                                                                                                                                                                                     Resolved

Abbreviations: IS, induced sputum; NP, nasopharyngeal; O~2~, oxygen; PERCH, Pneumonia Etiology Research for Child Health.

Children with SAEs were more likely than those without SAEs to be human immunodeficiency virus (HIV) exposed (46% of children with SAEs vs 18% of children without an SAE, *P* = .018) and to have very severe pneumonia (50% vs 29%, *P* = .062) ([Table 4](#T4){ref-type="table"}).

###### 

Characteristics of Cases With and Without a Serious Adverse Event^a^

  --------------------------------------------------------------------------------------------------------------
  Characteristics          Cases without an SAE (n = 3785^b^)   Cases with an SAE\   *P* Value^c^          
                                                                (n = 13)                                   
  ------------------------ ------------------------------------ -------------------- -------------- ------ -----
  Site                                                                                                     

   Kenya                   591                                  15.6                 3              23.1   .99

   The Gambia              592                                  15.6                 2              15.4   

   Mali                    544                                  14.4                 0              0.0    

   Zambia                  516                                  13.6                 2              15.4   

   South Africa            836                                  22.1                 5              38.5   

   Thailand                189                                  5.0                  1              7.7    

   Bangladesh              517                                  13.7                 0              0.0    

  Age                                                                                                      

   1--5 mo                 1539                                 40.7                 7              53.8   .79

   6--11 mo                858                                  22.7                 3              23.1   

   12--23 mo               859                                  22.7                 2              15.4   

   24--59 mo               529                                  14.0                 1              7.7    

  Female                   1587                                 41.9                 7              53.8   .41

  Severe malnutrition^d^   504                                  13.4                 3              23.1   .36

  Bronchiolitis^e^         740                                  19.8                 3              23.1   .92

  HIV positive^f^          203                                  5.4                  2              15.4   .24

  HIV exposed^g^           614                                  17.9                 6              46.2   .06

  Very severe pneumonia    1081                                 28.6                 7              50.0   .06

  Abnormal CXR^h^          1741                                 53.0                 9              75.0   .20
  --------------------------------------------------------------------------------------------------------------

Data are presented as No. (%).

Abbreviations: CXR, chest radiograph; ELISA, enzyme-linked immunosorbent assay; HIV, human immunodeficiency virus; PCR, polymerase chain reaction; SAE, serious adverse event; SD, standard deviation; WHO, World Health Organization.

^a^Among children who underwent an induced sputum procedure.

^b^This table does not include data for 4 children who had an SAE related to lung aspirates.

^c^Calculated from logistic regression (outcome = SAE) adjusted for site and age (site is adjusted for age only and age is adjusted for site only).

^d^WHO weight-for-age *z* score \< --3 SDs.

^e^Bronchiolitis reported as admission or discharge diagnoses or concurrent condition.

^f^HIV positive: detectable viral load or HIV seropositive if \>12 months old.

^g^HIV exposed: HIV positive, positive ELISA results (if \< 12 months), or positive maternal history (maternal history must be confirmed by maternal serology for seronegative infants \<7 months).

^h^Abnormal chest radiograph defined as presence of consolidation and/or other infiltrate.

In total, 31 (0.8%) children had the first IS procedure stopped because of a drop in oxygen saturation below 88% for \>60 seconds. An SAE was reported in 4 of these children (see above) and the study clinician was able to restart the IS procedure for the remaining 27 children after a period of stabilization (ie, the child's respiratory status improved and oxygen saturation was at least 92% for ≥5 minutes). Of the 851 children undergoing a second IS procedure, 14 (1.6%) had the procedure stopped due to a drop in oxygen saturation below 88% for \>60 seconds, and the procedure was reinitiated in all 14. There was no change in median oxygen requirement before and after the procedure. Five children (0.5%) required an oxygen increase of \>1 L/minute immediately after the procedure, compared to their baseline status ([Table 5](#T5){ref-type="table"}). The percentage of children requiring supplemental oxygen before the first induced sputum procedure (n = 1091 \[29.2%\]) dropped to 27.3% (n = 1019) by the last clinical monitoring time point at 4 hours postprocedure. There were no differences in consciousness level in the immediate period after the procedure. However, 20 children experienced a decrease in their consciousness level when comparing immediately before IS and any point during the 4-hour monitoring period after IS. Oxygen saturation remained steady at all monitoring time points ([Table 5](#T5){ref-type="table"}). Clinical measures were also analyzed separately for children who had a second IS, with no clinically significant changes found in that subset of children (Supplementary Table 1).

###### 

Clinical Measurements in Pneumonia Etiology Research for Child Health (PERCH) Study Cases Before and After First Induced Sputum Procedure (N = 3736^a^)

  Measurement                                         Immediately Before   Immediately After   30 Minutes After   2 Hours After    4 Hours After
  --------------------------------------------------- -------------------- ------------------- ------------------ ---------------- ----------------
  Oxygen flow, L/min^b^                                                                                                            
   No.                                                1091                 1048                1084               1044             1019
   Median (IQR)                                       2.0 (2.0--2.0)       2.0 (2.0--2.0)      2.0 (2.0--2.0)     2.0 (2.0--2.0)   2.0 (2.0--2.0)
   Median change from baseline (IQR)                  NA                   0                   0                  0                0
   No. (%) with increase of \>1 L/min from baseline   NA                   5 (0.5)             5 (0.5)            8 (0.7)          8 (0.7)
  Oxygen saturation, %                                                                                                             
   No.                                                3349                 3340                3347               3336             3324
   Median (IQR)                                       97 (95--99)          98 (96--99)         97 (95--99)        97 (96--99)      98 (96--99)
   Median change from baseline (IQR)                  NA                   0 (--1 to 2)        0 (--1 to 1)       0 (--1 to 1)     0 (--1 to 2)
   No. (%) on supplemental oxygen^c^                  1091 (32.6)          1048 (31.4)         1084 (32.4)        1044 (31.3)      1017 (30.6)
  Respiratory rate, breaths/min                                                                                                    
   No.                                                3513                 3525                3546               3542             3534
   Median (IQR)                                       52 (44--60)          54 (46--62)         51 (42--60)        50 (42--58)      48 (40--56)
   Median change from baseline (IQR)                  NA                   2 (--2 to 5)        0 (--4 to 3)       --2 (--6 to 2)   --2 (--8 to 1)
   No. (%) tachypneic^d^                              2357 (67.1)          2561 (72.7)         2308 (65.1)        2117 (59.8)      1986 (56.2)
  Consciousness level (AVPU scale)^e^                                                                                              
   No.                                                3538                 3528                3532               3524             3520
   No. (%) V, P, or U                                 10 (0.3)             10 (0.3)            12 (0.3)           9 (0.3)          7 (0.2)
   No. (%) with any decrease from baseline            NA                   5 (0.1)             7 (0.2)            4 (0.1)          4 (0.1)

Abbreviations: AVPU, alert, voice, pain, unresponsive; IQR, interquartile range; NA, not applicable (baseline measurement).

^a^A total of 66 children had no clinical monitoring data at any time point and have been excluded from this table.

^b^Among children on supplemental oxygen at respective monitoring time points.

^c^Two children on oxygen at 4 hours postprocedure did not have oxygen saturation data and are not included in the "n" of 1017.

^d^Tachypneic: ≥60 breaths per minute (bpm) for children \<2 months, ≥50 bpm for children 2--11 months, ≥40 bpm for children 12--59 months.

^e^AVPU = alert, voice, pain, unresponsive scale to assess consciousness level. V, P, and U means not alert (A), but responsive to voice (V) or pain (P), or unresponsive (U). Numbers and percentages for AVPU exclude children whose conscious level was unknown or who were pharmacologically sedated.

DISCUSSION {#s7}
==========

The IS procedure was generally well tolerated among a large and geographically heterogeneous group of children aged 1--59 months, hospitalized with WHO-defined severe or very severe pneumonia. Serious adverse events were very infrequent (n= 13 \[0.34%\]) as were the subset of SAEs that were assessed as probably, possibly, or definitely related to the IS procedure (n = 10 \[0.26%\]). To our knowledge, this is the first large-scale study that demonstrates a low rate of SAEs with IS collection in hospitalized children with severe or very severe pneumonia across multiple settings. This study demonstrates that IS collection can be safely performed in a large sample of children in typical resource-constrained hospital; however, vigilant monitoring for up to 2 hours postprocedure is necessary.

Our findings are consistent with the low rate of SAEs associated with IS collection shown in other studies among severely ill children \[[@CIT0015]\]. In 2 small case series of children with community-acquired pneumonia in Finland \[[@CIT0003]\] and in 2 PERCH pilot studies \[[@CIT0006], [@CIT0019]\], the IS procedure was found to be well tolerated and to produce sputum largely of good quality (defined as \<10 epithelial cells per high-power field) that contained high frequencies of bacterial and viral pathogens.

Two post-IS deaths reported as SAEs were both temporally associated with reinitiation of feeding following the IS procedure. The death that occurred in an infant who reinitiated breastfeeding approximately 2 hours after IS collection was assessed as "possibly related" to IS collection; 2 site clinicians, the site safety monitor, and 3 clinicians from the PERCH core team, including the central safety monitor, could not exclude that IS collection may have contributed to respiratory distress. The death that occurred in a toddler during cup feeding approximately 2 hours after IS was assessed as "probably not" related to IS collection. Following IS collection, it is advisable for a clinician to reassess patients prior to reinitiating feeding to ensure that the child's respiratory status is stable enough to tolerate oral intake.

The relatedness of the reported events to the IS procedure is difficult to conclude with confidence. All children undergoing the IS procedure were hospitalized with severe or very severe pneumonia, and many were severely ill. Distinguishing procedure-related clinical deterioration from the natural history of a child's illness is often not possible. It is conceivable that exposing children with pneumonia to hypertonic saline nebulized solution, while provoking coughing as the intended consequence, may also in rare circumstances exacerbate the underlying illness. With the amount of coughing that is induced, respiratory fatigue, aspiration of upper airway secretions, or inadequate respiration could impair the child's clinical status. Among the 10 events that were assessed as possibly, probably, or definitely related, 2 of the children required mechanical ventilation after IS and had prolonged hospital stays.

The clinical respiratory stability of children undergoing the procedure, as measured by oxygen saturation, oxygen requirement, respiratory rate, and consciousness level, remained remarkably unaffected by the procedure. Data from some children who experienced an SAE within the 4 hours following completion of the IS procedure are missing after the time of the event and not reflected in [Table 5](#T5){ref-type="table"}. Although this could bias results toward showing no change from baseline, this is unlikely to impact the interpretation of results given the small number of cases for whom data was not available because of an SAE. The oxygen requirement showed a general decreasing trend after the procedure and it is possible that IS may benefit a child with a congested chest as it loosens secretions and may improve airflow. Our findings suggest that frequent monitoring is useful up to 2 hours following the IS procedure, and that the PERCH approach was appropriate for the study and may be of use for implementation as part of clinical care in hospital environments. Because only 1 SAE was detected during the 2- to 4-hour post-IS monitoring period (among 3802 who had at least 1 IS), hospital resources may best be directed toward frequent oxygen saturation monitoring up to 2 hours postprocedure. Clinical monitoring data also suggested minimal differences at the 2- and 4-hour marks for oxygen saturation, a metric that may be readily assessable in resource-limited settings.

The rigorous clinical monitoring done for children in PERCH throughout the course of the IS specimen collection provides an opportunity to see the overall clinical effects in a large and heterogeneous study population of hospitalized children. These findings support IS as a relatively safe procedure in children with severe pneumonia. Although not statistically significant, the risk of an SAE after IS collection was higher among HIV-exposed compared with HIV-unexposed children, suggesting that a different risk-benefit assessment may apply to this subset of children. Clinicians caring for children with severe pneumonia have to consider the safety, feasibility, and utility of IS, among other factors, when considering whether the risk of the procedure is warranted. Our analysis addresses only 1 component of this decision matrix; the utility of IS in diagnosing the etiology of pneumonia in children is reported in a companion article \[[@CIT0020]\]. Additional limitations in the study include potential for practice variation and incomplete monitoring data ([Table 2](#T2){ref-type="table"}). Despite standardized protocols and twice-yearly refresher training on all study SOPs, local differences in practice, resources, staffing, and comfort levels with the IS procedure may have resulted in procedural, monitoring, and reporting variations.

The collection of an IS specimen was well tolerated in hospitalized children aged 1--59 months with severe or very severe pneumonia who were eligible for the procedure. Due to the potential for clinical deterioration, we recommend that clinicians who perform sputum induction in severely ill children consider implementing a clinical monitoring protocol to identify and treat any complications that may arise, with close attention to oxygen saturation levels during and for 2 hours following the procedure and a clinical assessment before reinitiating feeding.
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